Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Neoplasms of the CNS

Free Subscription Articles published in Neurol Res Retrieve available abstracts of 27 articles: HTML format

Single Articles

September 2025
1. ZHANG Z, Sha Z, Liu H, Chen Y, et al
   Integrated single-cell and spatial transcriptomics uncover the prognostic, epigenetic, and immunological roles of FANCC in low-grade glioma.
   Neurol Res. 2025 Sep 9:1-17. doi: 10.1080/01616412.2025.2556255.
   PubMed     Abstract available
   
   
   
2. ZHANG Y, Zhou P, Yu H
   Clinical significance and biological function of miR-3613-3p in glioma.
   Neurol Res. 2025 Sep 1:1-9. doi: 10.1080/01616412.2025.2551870.
   PubMed     Abstract available
   
   
   August 2025
3. CHEN S, Liu Z, Gao Y
   FAM111B as a biomarker influences the prognosis and immune microenvironment of low-grade gliomas.
   Neurol Res. 2025 Aug 10:1-18. doi: 10.1080/01616412.2025.2538129.
   PubMed     Abstract available
   
   
   July 2025
4. YIN J, Zhang X
   Abnormal expression of miR-136-5p in glioma cancer patients and its correlation with CT signs.
   Neurol Res. 2025 Jul 28:1-10. doi: 10.1080/01616412.2025.2532818.
   PubMed     Abstract available
   
   
   
5. ZHANG Z, Sha Z, Wang H, Chen Y, et al
   PSMC3IP as a prognostic biomarker and immunomodulatory regulator in low-grade glioma: insights from multi-omics and methylation analysis.
   Neurol Res. 2025 Jul 20:1-17. doi: 10.1080/01616412.2025.2528159.
   PubMed     Abstract available
   
   
   
6. CHEN W, Ren P, Huang GH, Liu JP, et al
   Machine learning-based preoperative prediction of IDH mutation status in adult gliomas using clinical features.
   Neurol Res. 2025 Jul 13:1-9. doi: 10.1080/01616412.2025.2533418.
   PubMed     Abstract available
   
   
   June 2025
7. HUANG C, Yu XB, Zhou YZ, Zhang XB, et al
   Multimerin-1 modulates macrophage M2 polarization and enhances tumor cell stemness in glioblastoma.
   Neurol Res. 2025 Jun 21:1-16. doi: 10.1080/01616412.2025.2520060.
   PubMed     Abstract available
   
   
   
8. HU H, Fan X, Wei J, Wang G, et al
   ITGA5 drives glioblastoma progression through SLK-mediated activation of the PI3K-Akt pathway.
   Neurol Res. 2025 Jun 21:1-11. doi: 10.1080/01616412.2025.2512437.
   PubMed     Abstract available
   
   
   
9. VARGHESE NE, John A, C UDA, Pillai MJ, et al
   Transformer-augmented lightweight U-Net (UAAC-Net) for accurate MRI brain tumor segmentation.
   Neurol Res. 2025 Jun 17:1-16. doi: 10.1080/01616412.2025.2517312.
   PubMed     Abstract available
   
   
   
10. OXMAN L, Tsur Y, Nimni M, Laviv Y, et al
    Brain metastases' radiologic phenotypes: correlation between tumor's consistency, extent of edema, histologic features and vascular territory affected.
    Neurol Res. 2025 Jun 13:1-15. doi: 10.1080/01616412.2025.2520013.
    PubMed     Abstract available
    
    
    April 2025
11. WANG T, Zhou J, Chen G, Xu X, et al
    SPP1 is associated with glioma malignancy and immunosuppressive regulation in 916 samples.
    Neurol Res. 2025 Apr 24:1-11. doi: 10.1080/01616412.2025.2497471.
    PubMed     Abstract available
    
    
    
12. JING S, Wang L, Liu W, Li C, et al
    ELK3 expression as a prognostic marker in patients with glioma.
    Neurol Res. 2025 Apr 8:1-7. doi: 10.1080/01616412.2025.2490088.
    PubMed     Abstract available
    
    
    March 2025
13. SUI A, Guo X
    Histone demethylase KDM6B promotes glioma cell proliferation by increasing PDGFRA expression via chromatin loop formation.
    Neurol Res. 2025 Mar 25:1-9. doi: 10.1080/01616412.2025.2480326.
    PubMed     Abstract available
    
    
    
14. ZHUO J, Zhang J, Xu Y, Ji M, et al
    Involvement of the disulfidptosis-related immune checkpoint gene, CD276, in glioblastoma malignant phenotype and poor prognosis.
    Neurol Res. 2025 Mar 13:1-14. doi: 10.1080/01616412.2025.2476506.
    PubMed     Abstract available
    
    
    November 2024
15. XIA J, Peng Z, Zhang M, Liao Q, et al
    MicroRNA-429 overexpression overcomes imatinib resistance of glioma cells by negatively regulating lysophosphatidic acid receptor 1.
    Neurol Res. 2024 Nov 12:1-11. doi: 10.1080/01616412.2024.2423586.
    PubMed     Abstract available
    
    
    September 2024
16. ZHU J, Shi L, Su Y
    FYN as an emerging biological biomarker for prognosis and potential therapeutic target in LGG.
    Neurol Res. 2024;46:787-795.
    PubMed     Abstract available
    
    
    August 2024
17. ZHU J, Zhang Y
    Dexmedetomidine inhibits the migration, invasion, and glycolysis of glioblastoma cells by lactylation of c-myc.
    Neurol Res. 2024 Aug 28:1-8. doi: 10.1080/01616412.2024.2395069.
    PubMed     Abstract available
    
    
    July 2024
18. EIBL T, Schrey M, Rossmann J, Liebert A, et al
    Resection of meningiomas located in motor eloquent areas - comparative analysis of navigated transcranial magnetic stimulation and conventional neuronavigation.
    Neurol Res. 2024 Jul 2:1-7. doi: 10.1080/01616412.2024.2370731.
    PubMed     Abstract available
    
    
    
19. MA C, Feng Y, Zhong K, Wei J, et al
    PKM2 promotes glioma progression by mediating CTNNB1 expression.
    Neurol Res. 2024;46:583-592.
    PubMed     Abstract available
    
    
    May 2024
20. AL-SALIHI MM, Rahman M, Al-Jebur MS, Al-Salihi Y, et al
    Effect of preservation versus resection of turbinate on olfactory function in endoscopic trans-nasal trans-sphenoidal pituitary surgery: a systematic review and meta-analysis.
    Neurol Res. 2024;46:444-452.
    PubMed     Abstract available
    
    
    
21. NGUYEN AV, Soto JM, Digbeu BD, Nguyen CY, et al
    Factors associated with longer survival among older medicare patients after diagnosis of supratentorial primary brain malignancies: a retrospective cohort study.
    Neurol Res. 2024;46:379-390.
    PubMed     Abstract available
    
    
    November 2023
22. ZHAO S, Li Y, Xu J, Shen L, et al
    APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Neurol Res. 2023 Nov 26:1-16. doi: 10.1080/01616412.2023.2287340.
    PubMed     Abstract available
    
    
    September 2023
23. ZHANG Y, Wang X, Chen G, Lu Y, et al
    Autocrine motility factor receptor promotes the malignancy of glioblastoma by regulating cell migration and invasion.
    Neurol Res. 2023 Sep 13:1-9. doi: 10.1080/01616412.2023.2257463.
    PubMed     Abstract available
    
    
    
24. ALIMOHAMMADI E, Lawton MT, Bagheri SR, Siahkamari E, et al
    High prognostic nutritional index could be associated with improved survival in patients with brain metastases: a retrospective observational study.
    Neurol Res. 2023 Sep 12:1-6. doi: 10.1080/01616412.2023.2257438.
    PubMed     Abstract available
    
    
    
25. TANG D, Hu Y, Gao W
    5-lipoxygenase as a target to sensitize glioblastoma to temozolomide treatment via beta-catenin-dependent pathway.
    Neurol Res. 2023 Sep 11:1-9. doi: 10.1080/01616412.2023.2255414.
    PubMed     Abstract available
    
    
    June 2023
26. ZHANG W, Wu Z
    COP1 facilitates the proliferation, invasion, and migration of glioma cells by ubiquitination of DLG3 protein.
    Neurol Res. 2023 Jun 25:1-9. doi: 10.1080/01616412.2022.2123173.
    PubMed     Abstract available
    
    
    April 2023
27. HUA W, Xu H, Zhang X, Yu G, et al
    Pure endoscopic resection of pineal region tumors through supracerebellar infratentorial approach with 'head-up' park-bench position.
    Neurol Res. 2023;45:354-362.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.